特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
642813

消化薬の世界市場:2018年~2022年

Global Digestive Remedies Market 2018-2022

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 122 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
消化薬の世界市場:2018年~2022年
出版日: 2018年05月11日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 122 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

消化薬について

消化薬は消化器(GI)障害の治療に使用されています。最も一般的な消化器疾患は、消化不良、胸やけ、下痢、過敏性腸症候群(IBS)、乗り物酔い、小児の消化器疾患、および便秘です。

Technavioのアナリストは、2018年から2022年の間に世界の消化薬市場が4.1%のCAGRで成長すると予測しています。

当レポートでは、世界の消化薬市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模(2017年)
  • 市場規模および予測(2017-2022年)

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第7章 市場セグメンテーション:アプリケーション別

  • セグメンテーション:アプリケーション別(2017-2022年)
  • 比較:アプリケーション別
  • IHR - 市場規模と予測
  • 下痢止め薬 - 市場規模と予測
  • その他 - 市場規模と予測
  • 市場機会:アプリケーション別

第8章 顧客情勢

第9章 地域情勢

  • 地域別セグメンテーション(2017-2022年)
  • 地域比較
  • 南北アメリカ - 市場規模と予測
  • 欧州・中東・アフリカ地域 - 市場規模と予測
  • アジア太平洋地域 - 市場規模と予測
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第12章 市場動向

  • 代替製品
  • 成長するオンライン薬局
  • 3D印刷薬

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck KGaA

第15章 付録

  • 略語のリスト
図表
  • Exhibit 01: Global metabolic disorder treatment market
  • Exhibit 02: Global metabolic disorder treatment market
  • Exhibit 03: Market characteristics
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Application - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by application
  • Exhibit 20: IHR - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 21: IHR - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Diarrhea remedies - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 23: Diarrhea remedies - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Others - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 25: Others - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by application
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 01: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 02: Top 3 countries in EMEA
  • Exhibit 03: APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 04: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 05: Top 3 countries in APAC
  • Exhibit 06: Market opportunity
  • Exhibit 07: Global population 65+ 2010-2017 (%)
  • Exhibit 08: Vendor landscape
  • Exhibit 09: Landscape disruption
  • Exhibit 10: Vendors covered
  • Exhibit 11: Vendor classification
  • Exhibit 12: Market positioning of vendors
  • Exhibit 13: Sanofi overview
  • Exhibit 14: Sanofi - Business segments
  • Exhibit 15: Sanofi - Organizational developments
  • Exhibit 16: Sanofi - Geographic focus
  • Exhibit 17: Sanofi - Segment focus
  • Exhibit 18: Sanofi - Key offerings
  • Exhibit 19: GlaxoSmithKline overview
  • Exhibit 20: GlaxoSmithKline - Business segments
  • Exhibit 21: GlaxoSmithKline - Organizational developments
  • Exhibit 22: GlaxoSmithKline - Geographic focus
  • Exhibit 23: GlaxoSmithKline - Segment focus
  • Exhibit 24: GlaxoSmithKline - Key offerings
  • Exhibit 25: Pfizer overview
  • Exhibit 26: Pfizer - Business segments
  • Exhibit 27: Pfizer - Organizational developments
  • Exhibit 28: Pfizer - Geographic focus
  • Exhibit 29: Pfizer - Segment focus
  • Exhibit 30: Pfizer - Key offerings
  • Exhibit 31: Bayer Healthcare overview
  • Exhibit 32: Bayer Healthcare - Business segments
  • Exhibit 33: Bayer Healthcare - Organizational developments
  • Exhibit 34: Bayer Healthcare - Geographic focus
  • Exhibit 35: Bayer Healthcare - Segment focus
  • Exhibit 36: Bayer Healthcare - Key offerings
  • Exhibit 37: Johnson & Johnson overview
  • Exhibit 38: Johnson & Johnson - Business segments
  • Exhibit 39: Johnson & Johnson - Organizational developments
  • Exhibit 40: Johnson & Johnson - Geographic focus
  • Exhibit 41: Johnson & Johnson - Segment focus
  • Exhibit 42: Johnson & Johnson - Key offerings
  • Exhibit 43: Merck KGaA overview
  • Exhibit 44: Merck KGaA - Business segments
  • Exhibit 45: Merck KGaA - Organizational developments
  • Exhibit 46: Merck KGaA- Geographic focus
  • Exhibit 47: Merck KGaA - Segment focus
  • Exhibit 48: Merck KGaA - Key offerings
目次
Product Code: IRTNTR22816

About Digestive Remedies

Digestive remedies are used for the treatment of gastrointestinal (GI) disorders. The most common digestive disorders are indigestion, heartburn, diarrhoea, irritable bowel syndrome (IBS), motion sickness, paediatric digestive disorders, and constipation.

Technavio's analysts forecast the Global Digestive Remedies Market to grow at a CAGR of 4.1% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the digestive remedies market. To calculate the market size, the report considers the revenue generated from the sales of digestive remedies.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Digestive Remedies Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck KGaA

Market driver

  • Availability of OTC products

Market challenge

  • Threat from counterfeit products

Market trend

  • Alternative products

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01 EXECUTIVE SUMMARY

PART 02 SCOPE OF THE REPORT

PART 03 RESEARCH METHODOLOGY

PART 04 MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05 MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06 FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07 MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • IHR - Market size and forecast 2017-2022
  • Diarrhea remedies - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by application

PART 08 CUSTOMER LANDSCAPE

PART 09 REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10 DECISION FRAMEWORK

PART 11 DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12 MARKET TRENDS

  • Alternative products
  • Growing online pharmacy
  • 3D printing drugs

PART 13 VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14 VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck KGaA

PART 15 APPENDIX

  • List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.